Innovative Eyewear Inc

On December 13, 2024, Harrison Gross, our Chief Executive Officer, adopted a Rule 10b5-1 trading plan, which was effective through August 31, 2025. The terms of this arrangement provided for (i) the sale of stock to cover Mr. Gross’ income tax withholding obligations associated with the issuance of 19,200 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of 2,880 shares of common stock. The aggregate number of shares sold pursuant to this arrangement during 2025 was 8,967.

On December 9, 2025, Harrison Gross, our Chief Executive Officer, adopted a Rule 10b5-1 trading plan, which is effective through August 31, 2026. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Gross’ income tax withholding obligations associated with the issuance of 49,200 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of 35% of the net shares of common stock received from such vesting, at the prevailing market price. As such, the estimated aggregate number of shares to be sold pursuant to this arrangement is 26,702.

On December 13, 2024, Konrad Dabrowski, who was at the time our Co-Chief Financial Officer, adopted a Rule 10b5-1 trading plan, which was effective through August 31, 2025. The terms of this arrangement provided for the sale of stock to cover Mr. Dabrowski’s income tax withholding obligations associated with the issuance of 16,800 shares of common stock in connection with the vesting of restricted stock units. The aggregate number of shares sold pursuant to this arrangement during 2025 was 5,296.

On December 9, 2025, Konrad Dabrowski, our Chief AI and Growth Officer, adopted a Rule 10b5-1 trading plan, which is effective through August 31, 2026. The terms of this arrangement provide for the sale of stock to cover Mr. Dabrowski’s income tax withholding obligations associated with the issuance of 41,800 shares of common stock in connection with the vesting of restricted stock units. As such, the estimated aggregate number of shares to be sold pursuant to this arrangement is 12,394.

On December 13, 2024, Oswald Gayle, who was at the time our Co-Chief Financial Officer, adopted a Rule 10b5-1 trading plan, which was effective through December 2, 2025. The terms of this arrangement provided for (i) the sale of stock to cover Mr. Gayle’s income tax withholding obligations associated with the issuance of 10,800 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 100% of the net vested shares of common stock at certain specified limit prices. The aggregate number of shares sold pursuant to this arrangement during 2025 was 8,935.

On December 9, 2025, Oswald Gayle, our Chief Financial Officer, adopted a Rule 10b5-1 trading plan, which is effective through August 31, 2026. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Gayle’s income tax withholding obligations associated with the issuance of 32,466 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of 4,870 shares of common stock received from such vesting at the prevailing market price. As such, the estimated aggregate number of shares to be sold pursuant to this arrangement is 14,496.

On December 13, 2024, David Eric Cohen, our Chief Technology Officer, adopted a Rule 10b5-1 trading plan, which was effective through December 2, 2025. The terms of this arrangement provided for (i) the sale of stock to cover Mr. Cohen’s income tax withholding obligations associated with the issuance of 14,400 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 3,038 of the net vested shares of common stock at certain specified limit prices. The aggregate number of shares sold pursuant to this arrangement during 2025 was 7,689.

On December 9, 2025, David Eric Cohen, our Chief Technology Officer, adopted a Rule 10b5-1 trading plan, which is effective through December 2, 2026. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Cohen’s income tax withholding obligations associated with the issuance of 36,400 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 7,440 of the net vested shares of common stock at certain specified limit prices. As such, the estimated minimum aggregate number of shares to be sold pursuant to this arrangement is 10,793, and the estimated maximum aggregate number of shares that may be sold pursuant to this arrangement is 18,233.

On December 13, 2024, Joaquin Abondano, our Chief Operating Officer, adopted a Rule 10b5-1 trading plan, which was effective through December 8, 2025. The terms of this arrangement provided for (i) the sale of stock to cover Mr. Abondano’s income tax withholding obligations associated with the issuance of 9,600 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 40% of the net vested shares of common stock at certain specified limit prices. The aggregate number of shares sold pursuant to this arrangement in 2025 was 4,389.

On December 9, 2025, Joaquin Abondano, our Chief Operating Officer, adopted a Rule 10b5-1 trading plan, which is effective through December 18, 2026. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Abondano’s income tax withholding obligations associated with the issuance of 29,600 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 40% of the net vested shares of common stock at certain specified limit prices. As such, the estimated minimum aggregate number of shares to be sold pursuant to this arrangement is 8,776, and the estimated maximum aggregate number of shares that may be sold pursuant to this arrangement is 17,106.